Skip to main content
TipRanks
Go Ultimate75% OFF

SAB Biotherapeutics (SABS) Q3 2022 Earnings Report

331 Followers

SABS Q3 2022 EPS Results

Actual EPS
-$1.60
Consensus EPS
-$1.43
Beat/Miss
Missed by -$0.17
One Year Ago EPS
-$0.20

SABS Q3 2022 Revenue Results

Actual Revenue
$3.59M
Expected Revenue
$6.85M
Beat/Miss
Missed by -$3.26M
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q3 2022
Date
11/15/2022
Time
Before Open
Conference Call
Tuesday, November 15, 2022
SABS Upcoming Earnings

SAB Biotherapeutics's next earnings date is estimated for April 1, 2027, based on past reporting schedules.

Q3 2022 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q3 2022 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

SABS Earnings History

SABS earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Apr 01, 20272026 (Q4)-0.24--0.35――
Nov 05, 20262026 (Q3)-0.28-0.24-0.21-14.29% (-0.03)
Aug 06, 20262026 (Q2)-0.29-0.28-1.0974.31% (+0.81)
May 12, 20262026 (Q1)-0.21-0.35-0.5637.50% (+0.21)
Mar 26, 20262025 (Q4)-0.21-0.27-1.2378.05% (+0.96)
Nov 13, 20252025 (Q3)-0.46-0.21-1.1281.25% (+0.91)
Aug 07, 20252025 (Q2)-0.80-1.09-0.79-37.97% (-0.30)
May 09, 20252025 (Q1)―--0.54―
Mar 31, 20252024 (Q4)-1.07-0.56-0.54-3.70% (-0.02)
Nov 06, 20242024 (Q3)-1.11-1.12-1-12.00% (-0.12)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed